nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation
|
McDonald, George B. |
|
2006 |
19 |
2 |
p. 341-352 12 p. |
artikel |
2 |
Aims & scope/editorial board
|
|
|
2006 |
19 |
2 |
p. v- 1 p. |
artikel |
3 |
Are matched unrelated donor transplants justified for AML in CR1?
|
Anasetti, Claudio |
|
2006 |
19 |
2 |
p. 321-328 8 p. |
artikel |
4 |
Autologous immune strategies to reduce the risk of leukemic relapse: Consideration for IL-15
|
Blaser, Bradley W. |
|
2006 |
19 |
2 |
p. 281-292 12 p. |
artikel |
5 |
Familial leukemia
|
Benson, Kathleen F. |
|
2006 |
19 |
2 |
p. 269-279 11 p. |
artikel |
6 |
Genomic approaches in acute leukemia
|
Stegmaier, Kimberly |
|
2006 |
19 |
2 |
p. 263-268 6 p. |
artikel |
7 |
Hematopoietic cell transplantation in first complete remission versus early relapse
|
Appelbaum, Frederick R. |
|
2006 |
19 |
2 |
p. 333-339 7 p. |
artikel |
8 |
History of the treatment of childhood ALL: A paradigm for cancer cure
|
Simone, Joseph V. |
|
2006 |
19 |
2 |
p. 353-359 7 p. |
artikel |
9 |
How good is allogeneic transplantation for high-risk patients with AML?
|
Messner, Hans A. |
|
2006 |
19 |
2 |
p. 329-332 4 p. |
artikel |
10 |
Is there a role for consolidation therapy pre-transplantation?
|
Rowe, Jacob M. |
|
2006 |
19 |
2 |
p. 301-310 10 p. |
artikel |
11 |
Myelodysplasia: When to treat and how
|
Larson, Richard A. |
|
2006 |
19 |
2 |
p. 293-300 8 p. |
artikel |
12 |
New agents for the treatment of acute myeloid leukemia
|
Tallman, Martin S. |
|
2006 |
19 |
2 |
p. 311-320 10 p. |
artikel |
13 |
[No title]
|
Rowe, Jacob M. |
|
2006 |
19 |
2 |
p. 259-262 4 p. |
artikel |